Wells Fargo & Company HALOZYME THERAPEUTICS INC Transaction History

Wells Fargo & Company

2,738,000

Previous 8,480,000 67.71%

Previous $0 NaN%

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	N/A	-5,742,000 Reduced 67.71%	2,738,000 $0
Q1 2025 May 13, 2025	BUY	N/A	1,934,000 Added 29.54%	8,480,000 $0
Q4 2024 Feb 12, 2025	BUY	N/A	1,871,000 Added 40.02%	6,546,000 $0
Q3 2024 Nov 13, 2024	SELL	N/A	-10,062,000 Reduced 68.28%	4,675,000 $0
Q2 2024 Aug 13, 2024	SELL	N/A	-662,000 Reduced 4.3%	14,737,000 $0
Q1 2024 May 10, 2024	BUY	N/A	474,000 Added 3.18%	15,399,000 $0
Q4 2023 Feb 09, 2024	BUY	N/A	534,000 Added 3.71%	14,925,000 $0
Q3 2023 Nov 13, 2023	BUY	N/A	4,292,000 Added 42.5%	14,391,000 $0
Q2 2023 Aug 15, 2023	BUY	N/A	6,892,000 Added 214.9%	10,099,000 $0
Q1 2023 May 12, 2023	BUY	N/A	1,229,000 Added 62.13%	3,207,000 $0
Q4 2022 Feb 13, 2023	BUY	N/A	1,000,000 Added 102.25%	1,978,000 $0
Q3 2022 Nov 14, 2022	BUY	N/A	150,000 Added 18.12%	978,000 $834,000
Q2 2022 Aug 12, 2022	SELL	N/A	-1,000,000 Reduced 54.7%	828,000 $737,000
Q1 2022 May 16, 2022	BUY	N/A	1,828,000 New	1,828,000 $1.6 Million

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.